Gao, M.; Heng, X.; Jin, J.; Chu, W.
Gypenoside XLIX Ameliorate High-Fat Diet-Induced Atherosclerosis via Regulating Intestinal Microbiota, Alleviating Inflammatory Response and Restraining Oxidative Stress in ApoE−/− Mice. Pharmaceuticals 2022, 15, 1056.
https://doi.org/10.3390/ph15091056
AMA Style
Gao M, Heng X, Jin J, Chu W.
Gypenoside XLIX Ameliorate High-Fat Diet-Induced Atherosclerosis via Regulating Intestinal Microbiota, Alleviating Inflammatory Response and Restraining Oxidative Stress in ApoE−/− Mice. Pharmaceuticals. 2022; 15(9):1056.
https://doi.org/10.3390/ph15091056
Chicago/Turabian Style
Gao, Ming, Xing Heng, Jing Jin, and Weihua Chu.
2022. "Gypenoside XLIX Ameliorate High-Fat Diet-Induced Atherosclerosis via Regulating Intestinal Microbiota, Alleviating Inflammatory Response and Restraining Oxidative Stress in ApoE−/− Mice" Pharmaceuticals 15, no. 9: 1056.
https://doi.org/10.3390/ph15091056
APA Style
Gao, M., Heng, X., Jin, J., & Chu, W.
(2022). Gypenoside XLIX Ameliorate High-Fat Diet-Induced Atherosclerosis via Regulating Intestinal Microbiota, Alleviating Inflammatory Response and Restraining Oxidative Stress in ApoE−/− Mice. Pharmaceuticals, 15(9), 1056.
https://doi.org/10.3390/ph15091056